olprinone has been researched along with bilirubin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bramanti, P; Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Mazzon, E | 1 |
Fukumoto, K; Hatano, E; Iguchi, K; Kasai, Y; Okamoto, T; Okuno, M; Sato, M; Taura, K; Uemoto, S; Ueno, K; Yamamoto, G; Yamanaka, K | 1 |
2 other study(ies) available for olprinone and bilirubin
Article | Year |
---|---|
Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice.
Topics: Alanine Transaminase; Alkaline Phosphatase; Amylases; Animals; Apoptosis; Ascitic Fluid; Aspartate Aminotransferases; bcl-2-Associated X Protein; Bicarbonates; Bilirubin; Blood Gas Analysis; Body Weight; Cell Count; Creatinine; Fas Ligand Protein; Hydrogen-Ion Concentration; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-1beta; Kidney; Lipase; Liver; Lung; Male; Mice; Mice, Inbred Strains; Multiple Organ Failure; Nitrates; Nitrites; P-Selectin; Pancreas; Phosphodiesterase 3 Inhibitors; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Pyridones; Survival Analysis; Tumor Necrosis Factor-alpha; Tyrosine; Zymosan | 2011 |
Hepatoprotective effect by pretreatment with olprinone in a swine partial hepatectomy model.
Topics: Animals; Bilirubin; Biopsy; Edema; Endothelial Cells; Enzyme Inhibitors; Female; Hemodynamics; Hepatectomy; Imidazoles; Immunohistochemistry; Laparotomy; Liver; Liver Transplantation; Microscopy, Electron; Nitric Oxide Synthase Type III; Phosphodiesterase 3 Inhibitors; Portal Pressure; Postoperative Period; Prothrombin; Pyridones; Swine; Swine, Miniature; Translational Research, Biomedical; Treatment Outcome | 2014 |